Neonatal Urinary Tract Infectious Disease malady

Categories: Nephrological diseases

Aliases & Classifications for Neonatal Urinary Tract Infectious Disease

Aliases & Descriptions for Neonatal Urinary Tract Infectious Disease:

Name: Neonatal Urinary Tract Infectious Disease 12
Urinary Tract Infection of Newborn 12


External Ids:

Disease Ontology 12 DOID:1375
ICD10 33 P39.3
ICD9CM 35 771.82
SNOMED-CT 64 12301009
UMLS 69 C0235815

Summaries for Neonatal Urinary Tract Infectious Disease

MalaCards based summary : Neonatal Urinary Tract Infectious Disease, is also known as urinary tract infection of newborn. The drugs Hyaluronic acid and Cefuroxime have been mentioned in the context of this disorder.

Related Diseases for Neonatal Urinary Tract Infectious Disease

Symptoms & Phenotypes for Neonatal Urinary Tract Infectious Disease

Drugs & Therapeutics for Neonatal Urinary Tract Infectious Disease

Drugs for Neonatal Urinary Tract Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 167)
id Name Status Phase Clinical Trials Cas Number PubChem Id
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
Tobramycin Approved, Investigational Phase 4,Phase 3 32986-56-4 5496 36294
Tazobactam Approved Phase 4 89786-04-9 123630
5 Adjuvants, Immunologic Phase 4
6 Protective Agents Phase 4,Phase 1
7 Viscosupplements Phase 4
8 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2
10 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
11 Antitubercular Agents Phase 4,Phase 2
12 cefuroxime axetil Phase 4
13 beta-Lactamase Inhibitors Phase 4
14 Ceftolozane, tazobactam drug combination Phase 4
15 Cephalosporins Phase 4
16 Penicillanic Acid Phase 4
17 Renal Agents Phase 4,Phase 3,Phase 2,Phase 1
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
Nitrofurantoin Approved, Vet_approved Phase 3 67-20-9 5353830
Chlorhexidine Approved, Vet_approved Phase 3,Phase 2 55-56-1 9552079 2713
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
Levofloxacin Approved, Investigational Phase 3,Phase 2,Phase 1 100986-85-4 149096
Ofloxacin Approved Phase 3,Phase 2,Phase 1 82419-36-1 4583
Azithromycin Approved Phase 3 83905-01-5 55185 53477736 447043
chloroquine Approved, Vet_approved Phase 3 54-05-7 2719
Pyrimethamine Approved, Vet_approved Phase 3 58-14-0 4993
Sulfadoxine Approved Phase 3 2447-57-6 17134
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
leucovorin Approved, Nutraceutical Phase 3,Phase 2 58-05-9 54575, 6560146 143
30 Clindamycin palmitate Phase 3
31 Clindamycin phosphate Phase 3
32 Anti-Infective Agents, Local Phase 3,Phase 2
33 Chlorhexidine gluconate Phase 3,Phase 2
34 Dermatologic Agents Phase 3,Phase 2
35 Disinfectants Phase 3,Phase 2
36 Antibodies Phase 2, Phase 3
37 gamma-Globulins Phase 2, Phase 3
38 Immunoglobulins Phase 2, Phase 3
39 Immunoglobulins, Intravenous Phase 2, Phase 3
40 Pharmaceutical Solutions Phase 2, Phase 3, Phase 1
41 Rho(D) Immune Globulin Phase 2, Phase 3
42 11-hydroxyprogesterone Phase 3
43 17-alpha-hydroxy-progesterone caproate Phase 3
44 Estrogen Antagonists Phase 3
45 Estrogens Phase 3
46 Hormone Antagonists Phase 3
47 Hormones Phase 3
48 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3
49 Progestins Phase 3
50 Cytochrome P-450 CYP1A2 Inhibitors Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show all 42)
id Name Status NCT ID Phase
1 A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children Unknown status NCT02271035 Phase 4
2 Antibiotics and Gut Microbiota Among Newborn Infants Completed NCT02072798 Phase 4
3 Circadian Rhythm In Tobramycin Elimination In Cystic Fibrosis Completed NCT01207245 Phase 4
4 Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients Completed NCT02421120 Phase 4
5 RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section Withdrawn NCT02009098 Phase 4
6 Maternal Genitourinary Infections and Adverse Perinatal Outcomes Unknown status NCT01572532 Phase 3
7 Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis Unknown status NCT00163852 Phase 2, Phase 3
8 Chlorhexidine Vaginal and Infant Wash in Pakistan Completed NCT00121394 Phase 3
9 Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection Completed NCT01203345 Phase 2, Phase 3
10 Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) Completed NCT00099164 Phase 3
11 Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients Completed NCT01270347 Phase 3
12 MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis Completed NCT01180634 Phase 3
13 Evaluation of Bladder Stimulation as a Noninvasive Technique of Urine Collection in Infant Who Have Not Acquired Walking Recruiting NCT02749188 Phase 3
14 A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix Recruiting NCT02518594 Phase 3
15 Protecting From Pneumococcus in Early Life (The PROPEL Trial) Recruiting NCT02628886 Phase 3
16 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3
17 Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients Completed NCT00677365 Phase 2
18 Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) Active, not recruiting NCT01594827 Phase 2
19 The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section Not yet recruiting NCT02742948 Phase 2
20 Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Terminated NCT01349192 Phase 2
21 Evaluation of Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters Completed NCT02277171 Phase 1
22 Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis Completed NCT00503490 Phase 1
23 "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients" Completed NCT00840333 Phase 1
24 Prebiotic in Preventing Low Birth Weight Recruiting NCT02721225 Phase 1
25 Effect of Use of a New Technique for Pediatric Urine Collection in ER Unknown status NCT02117102
26 The Use of Cranberries in Women With Preterm Premature Rupture of Membranes Unknown status NCT00247104
27 Laparoscopic or Conventional Mesh Repair of Incisional and Umbilical Hernia Unknown status NCT00970515
28 Evaluation of a Novel Midstream Urine Collection Technique for Infants in the Emergency Department Completed NCT02381834
29 Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients Completed NCT01180023
30 Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial Completed NCT02528981
31 Digestive and Nutritional Effects of Probiotics Supplementation in Premature Newborns Completed NCT00290576
32 Reduction of Infection in Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality Recruiting NCT02600195
33 Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Recruiting NCT01431326
34 The Association Between the Transfer of Lactobacilli From the Gastrointestinal Tract to the Vagina and the Prevention / Eradication of Abnormal Vaginal Flora in High Risk Pregnancies Recruiting NCT02430246
35 Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study Recruiting NCT02795845
36 NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health Recruiting NCT02812914
37 Oropharyngeal Administration of Mother's Colostrum for Premature Infants Recruiting NCT02116699
38 A Study of Home Monitoring in Adults With Cystic Fibrosis (HOMECF) Recruiting NCT02994706
39 Special Drug Use Investigation of Ciproxan Injection in Pediatrics Recruiting NCT02555059
40 Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention Not yet recruiting NCT03093194
41 Breast Feeding Practice in High Risk Pregnant Women Not yet recruiting NCT03178916
42 Suprapubic Aspiration Versus Urinary Catheterization In Neonates. Terminated NCT01726166

Search NIH Clinical Center for Neonatal Urinary Tract Infectious Disease

Genetic Tests for Neonatal Urinary Tract Infectious Disease

Anatomical Context for Neonatal Urinary Tract Infectious Disease

Publications for Neonatal Urinary Tract Infectious Disease

Variations for Neonatal Urinary Tract Infectious Disease

Expression for Neonatal Urinary Tract Infectious Disease

Search GEO for disease gene expression data for Neonatal Urinary Tract Infectious Disease.

Pathways for Neonatal Urinary Tract Infectious Disease

GO Terms for Neonatal Urinary Tract Infectious Disease

Sources for Neonatal Urinary Tract Infectious Disease

9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
32 HPO
33 ICD10
34 ICD10 via Orphanet
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
52 Novoseek
55 OMIM via Orphanet
59 PubMed
65 SNOMED-CT via Orphanet
68 Tocris
70 UMLS via Orphanet
Loading form....